Identifiable SMA percentages compared across ROIs in patients with brain tumor
| Target Group | Percentage Identified (95% CI) | Reference Group Percentage Identified (95% CI) | P Valuea |
|---|---|---|---|
| Hand | Hand (both) | ||
| Hand (right) | 75.8 (63.4–85.1) | 95.5 (86.4–98.8) | <.001b |
| Hand (left) | 75.8 (63.4–85.1) | 95.5 (86.4–98.8) | <.001b |
| Orofacial | Orofacial (both) | ||
| Orofacial (right) | 25.8 (16.1–38.2) | 34.8 (23.8–47.7) | .074 |
| Orofacial (left) | 27.3 (17.4–39.8) | 34.8 (23.8–47.7) | .041 |
| Hand (both) | 95.5 (86.4–98.8) | 34.8 (23.8–47.7) | <.001b |